Taiwan
· Delayed Price · Currency is TWD PharmaEssentia Statistics
Total Valuation
PharmaEssentia has a market cap or net worth of TWD 229.69 billion. The enterprise value is 210.71 billion.
| Market Cap | 229.69B |
| Enterprise Value | 210.71B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PharmaEssentia has 330.97 million shares outstanding. The number of shares has increased by 9.80% in one year.
| Shares Outstanding | 330.97M |
| Shares Change (YoY) | +9.80% |
| Shares Change (QoQ) | -1.73% |
| Owned by Insiders (%) | 8.66% |
| Owned by Institutions (%) | 9.73% |
| Float | 254.91M |
Valuation Ratios
The trailing PE ratio is 173.71 and the forward PE ratio is 44.89.
| PE Ratio | 173.71 |
| Forward PE | 44.89 |
| PS Ratio | 33.17 |
| PB Ratio | 9.10 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 159.06 |
| EV / Sales | 30.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1,770.96 |
Financial Position
The company has a current ratio of 12.78, with a Debt / Equity ratio of 4.25.
| Current Ratio | 12.78 |
| Quick Ratio | 11.97 |
| Debt / Equity | 4.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -9.05 |
| Interest Coverage | -14.88 |
Financial Efficiency
Return on equity (ROE) is 5.24% and return on invested capital (ROIC) is -0.76%.
| Return on Equity (ROE) | 5.24% |
| Return on Assets (ROA) | -0.71% |
| Return on Capital (ROIC) | -0.76% |
| Revenue Per Employee | 52.77M |
| Profits Per Employee | 10.11M |
| Employee Count | 131 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 0.68 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.23% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +89.23% |
| 50-Day Moving Average | 661.38 |
| 200-Day Moving Average | 436.37 |
| Relative Strength Index (RSI) | 55.38 |
| Average Volume (20 Days) | 2,254,058 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PharmaEssentia had revenue of TWD 6.91 billion and earned 1.32 billion in profits. Earnings per share was 4.00.
| Revenue | 6.91B |
| Gross Profit | 6.05B |
| Operating Income | -317.03M |
| Pretax Income | 1.24B |
| Net Income | 1.32B |
| EBITDA | -215.61M |
| EBIT | -317.03M |
| Earnings Per Share (EPS) | 4.00 |
Balance Sheet
The company has 20.06 billion in cash and 1.08 billion in debt, giving a net cash position of 18.98 billion or 57.36 per share.
| Cash & Cash Equivalents | 20.06B |
| Total Debt | 1.08B |
| Net Cash | 18.98B |
| Net Cash Per Share | 57.36 |
| Equity (Book Value) | 25.32B |
| Book Value Per Share | 76.26 |
| Working Capital | 21.95B |
Cash Flow
In the last 12 months, operating cash flow was 896.97 million and capital expenditures -1.02 billion, giving a free cash flow of -118.98 million.
| Operating Cash Flow | 896.97M |
| Capital Expenditures | -1.02B |
| Free Cash Flow | -118.98M |
| FCF Per Share | -0.36 |
Margins
Gross margin is 87.46%, with operating and profit margins of -4.59% and 19.16%.
| Gross Margin | 87.46% |
| Operating Margin | -4.59% |
| Pretax Margin | 17.90% |
| Profit Margin | 19.16% |
| EBITDA Margin | -3.12% |
| EBIT Margin | -4.59% |
| FCF Margin | -1.72% |
Dividends & Yields
PharmaEssentia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.80% |
| Shareholder Yield | -9.80% |
| Earnings Yield | 0.58% |
| FCF Yield | -0.05% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |